| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
43,990,000 |
| Market
Cap: |
679.21(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$12.17 - $24.61 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile REGENXBIO is a clinical-stage biotechnology company. Co.'s product candidates include: RGX-314, which is being developed as a gene therapy for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other additional chronic retinal conditions which cause total or partial vision loss for patients in the U.S., Europe and Japan; RGX-121, which is for the treatment of Mucopolysaccharidosis Type II; RGX-111, which is for the treatment of Mucopolysaccharidosis Type I; RGX-181, which is for the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease; and RGX-381, which is for the treatment of ocular manifestations of CLN2 disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
57,878 |
165,115 |
165,115 |
195,533 |
| Total Sell Value |
$1,217,382 |
$3,085,988 |
$3,085,988 |
$4,069,195 |
| Total People Sold |
2 |
2 |
2 |
3 |
| Total Sell Transactions |
4 |
7 |
7 |
14 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-02-08 |
4 |
AS |
$49.11 |
$63,843 |
D/D |
(1,300) |
16,372 |
|
-23% |
|
| Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-02-08 |
4 |
OE |
$12.10 |
$15,730 |
D/D |
1,300 |
17,672 |
|
- |
|
| Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-02-02 |
4 |
AS |
$44.77 |
$447,880 |
D/D |
(10,000) |
16,372 |
|
-17% |
|
| Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-02-02 |
4 |
OE |
$12.10 |
$121,000 |
D/D |
10,000 |
26,372 |
|
- |
|
| Mills Kenneth T. |
President and CEO |
• • – |
2021-01-25 |
4 |
AS |
$42.64 |
$290,779 |
D/D |
(6,500) |
280,984 |
|
-21% |
|
| Mills Kenneth T. |
President and CEO |
• • – |
2021-01-25 |
4 |
OE |
$0.85 |
$5,525 |
D/D |
6,500 |
287,484 |
|
- |
|
| Vasista Vittal |
Chief Financial Officer |
• – – |
2021-01-15 |
4 |
AS |
$50.04 |
$12,610 |
D/D |
(252) |
113,640 |
|
-27% |
|
| Simpson Curran |
Chief Oper. & Tech. Officer |
• – – |
2021-01-14 |
4 |
AS |
$50.01 |
$580,716 |
D/D |
(11,612) |
17,748 |
|
-32% |
|
| Simpson Curran |
Chief Oper. & Tech. Officer |
• – – |
2021-01-14 |
4 |
OE |
$19.50 |
$395,498 |
D/D |
11,612 |
29,360 |
|
- |
|
| Vasista Vittal |
Chief Financial Officer |
• – – |
2021-01-14 |
4 |
AS |
$50.03 |
$554,983 |
D/D |
(11,093) |
113,892 |
|
-32% |
|
| Simpson Curran |
Chief Oper. & Tech. Officer |
• – – |
2021-01-12 |
4 |
AS |
$50.03 |
$85,051 |
D/D |
(1,700) |
17,748 |
|
-28% |
|
| Simpson Curran |
Chief Oper. & Tech. Officer |
• – – |
2021-01-12 |
4 |
OE |
$19.50 |
$33,150 |
D/D |
1,700 |
19,448 |
|
- |
|
| Vasista Vittal |
Chief Financial Officer |
• – – |
2021-01-12 |
4 |
AS |
$50.01 |
$210,042 |
D/D |
(4,200) |
124,985 |
|
-28% |
|
| Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-01-12 |
4 |
AS |
$49.15 |
$67,729 |
D/D |
(1,378) |
16,372 |
|
-28% |
|
| Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-01-12 |
4 |
OE |
$19.50 |
$26,871 |
D/D |
1,378 |
17,750 |
|
- |
|
| Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-01-11 |
4 |
AS |
$49.08 |
$496,788 |
D/D |
(10,122) |
16,372 |
|
-26% |
|
| Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-01-11 |
4 |
OE |
$12.10 |
$141,879 |
D/D |
10,122 |
26,494 |
|
- |
|
| Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-01-08 |
4 |
AS |
$46.43 |
$470,565 |
D/D |
(10,000) |
16,372 |
|
-25% |
|
| Christmas Patrick J. |
Chief Legal Officer |
• – – |
2021-01-08 |
4 |
OE |
$12.10 |
$121,000 |
D/D |
10,000 |
26,372 |
|
- |
|
| Vasista Vittal |
Chief Financial Officer |
• – – |
2021-01-08 |
4 |
AS |
$46.45 |
$246,715 |
D/D |
(5,241) |
129,185 |
|
-25% |
|
| Simpson Curran |
Chief Oper. & Tech. Officer |
• – – |
2021-01-07 |
4 |
AS |
$50.01 |
$259,302 |
D/D |
(5,185) |
17,748 |
|
-28% |
|
| Simpson Curran |
Chief Oper. & Tech. Officer |
• – – |
2021-01-07 |
4 |
OE |
$19.50 |
$101,108 |
D/D |
5,185 |
22,933 |
|
- |
|
| Mills Kenneth T. |
President and CEO |
• • – |
2021-01-07 |
4 |
AS |
$50.01 |
$75,015 |
D/D |
(1,500) |
281,984 |
|
-28% |
|
| Mills Kenneth T. |
President and CEO |
• • – |
2021-01-07 |
4 |
OE |
$0.85 |
$1,275 |
D/D |
1,500 |
283,484 |
|
- |
|
| Vasista Vittal |
Chief Financial Officer |
• – – |
2021-01-07 |
4 |
AS |
$50.00 |
$549,900 |
D/D |
(10,998) |
134,426 |
|
-28% |
|
404 Records found
|
|
Page 5 of 17 |
|
|
0.24 (1.53%) 
